Tagged abuse-potential-assessment
Press Release
Crossing the Blood-Brain Barrier - the Human Element of Abuse Potential Assessment, New Webinar Hosted by Xtalks
CNS drug developers have to focus on physical safety and efficacy first, especially when developing products for rare disorders or diagnoses that are often unresponsive to other therapies. Although these products rarely have notable CNS mediated side effects, they fall under the FDA's requirement for an abuse potential assessment because they cross the blood-brain barrier. Read More
Press Release